Grants to advance research and patient support
Kyowa Kirin funds research and education projects on rare blood cancers and bone/mineral diseases, focusing on innovative therapies and reducing disparities, especially in CTCL.
Funder: Kyowa Kirin
Due Dates: July 31, 2026 (CTCL CME RFP) | August 20, 2020 (Patient Education Grant Program, historic) | December 10, 2020 (Patient Education Grant Program, historic)
Funding Amounts: CTCL CME RFP: $5,000–$100,000 per project; Patient Education Grant: up to $35,000 per project; total pool up to $100,000 per program.
Summary: Supports independent research, education, and patient advocacy projects focused on rare hematologic cancers and bone/mineral diseases, especially those addressing disparities or advancing innovative therapies.
Key Information: Individual HCPs and physician practices are not eligible; proposals due 90 days before project start.
Description
Kyowa Kirin provides a range of grants to support independent research, education, and patient advocacy initiatives that align with its mission to improve outcomes for patients, families, and medical professionals. The grants emphasize rare hematologic cancers and diseases (including cutaneous T-cell lymphoma, CTCL) and bone/mineral diseases, with a focus on advanced therapeutic antibodies and hematopoietic stem cell gene therapies. Funding is available for independent medical education (CME), fellowships, data collection, patient registries, investigator-sponsored research, new research publications, patient education resources, and outreach to underserved populations. The company aims to empower organizations and researchers to drive new data, education, and patient empowerment programs, particularly those addressing healthcare disparities.
